NCT00960570 - Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Healthy

Interventions

DRUG

Efavirenz 600 mg

Efavirenz 600 mg administered as a single oral dose on the morning of Day 1.

DRUG

Efavirenz 600 mg

Co-administered single oral doses of Efavirenz 600 mg and Fenofibric Acid 105 mg on Day 31.

DRUG

Fenofibric Acid

Co-administered single oral doses of Efavirenz 600 mg and Fenofibric Acid 105 mg on Day 31.